Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk. (January 2022) - He, Heng
Abstract: Objective: Bisphenol A (BPA), a common endocrine disrupter, can be activated by cytochrome P450 (CYP) metabolizing enzymes and might influence the development of breast cancer (BC). We hypothesized that BPA could interact with CYP genes, synergistically contributing to the BC risk. Methods: Urinary BPA was measured in a total of 302 newly diagnosed BC patients and 302 healthy controls by ultra-high performance liquid chromatography-high resolution mass spectrometry. A set of seven CYP gene polymorphisms was genotyped by using the Sequenom MassARRAY system. A multivariate logistic regression model was used to assess the associations of BPA and BPA-SNP interaction with BC risk. Results: BC patients had a higher urinary BPA concentration than healthy individuals ( P < 0.001). Each 1-unit increase in log-transformed urinary BPA was associated with a 54 % increased BC risk [95 % confidence interval (CI), 1.34–1.77, P < 0.001]. Individuals with the CYP19A1 rs1902580 GA + AA genotype showed a significantly higher BC risk than those with the GG genotype (OR = 1.45, 95 % CI, 1.01–2.09, P < 0.05). A significant BPA- CYP17A1 rs743572 interaction was found to be associated with a higher risk of BC ( P interaction = 0.020). Compared with low-BPA individuals carrying CYP17A1 rs743572 GG genotypes, high-BPA individuals with the GA + AA genotype had a higher BC risk, with an odds ratio of 2.49 (95 % CI, 1.52–4.13, P < 0.05). Conclusions: The positive association of BPA exposure with BC risk might be modified by CYP17A1 rs743572, providing evidence for the interaction effect of environment-genes on the etiology of BC. Highlights: Urinary bisphenol A (BPA) was positively associated with increased breast cancer (BC) risk. CYP19A1 rs1902580 genotype showed significant association with BC risk. BPA- CYP17A1 rs743572 interaction was associated with the risk of BC.